Tade Brad L. has filed 9 insider transactions across 1 company since July 2024.
Most recent transaction: a tax payment of 6479 shares of ADMA BIOLOGICS, INC. ($ADMA) on February 19, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | ADMA BIOLOGICS, INC. | $ADMA | Tade Brad L. | CFO and Treasurer | F | Common Stock | 6479 | $16.32 | 232,940.0000 | 243,342,466 | 2.71% | 0.00% |
| July 24, 2025 | ADMA BIOLOGICS, INC. | $ADMA | Tade Brad L. | CFO and Treasurer | F | Common Stock | 7123 | $17.31 | 239,419.0000 | 243,342,466 | 2.89% | 0.00% |
| June 26, 2025 | ADMA BIOLOGICS, INC. | $ADMA | Tade Brad L. | CFO and Treasurer | F | Common Stock | 9838 | $18.40 | 246,542.0000 | 243,342,466 | 3.84% | 0.00% |
| Feb. 26, 2025 | ADMA BIOLOGICS, INC. | $ADMA | Tade Brad L. | CFO and Treasurer | F | Common Stock | 5280 | $15.78 | 256,380.0000 | 243,342,466 | 2.02% | 0.00% |
| Feb. 19, 2025 | ADMA BIOLOGICS, INC. | $ADMA | Tade Brad L. | CFO and Treasurer | A | Common Stock | 62227 | $0.00 | 261,660.0000 | 243,342,466 | 31.20% | 0.03% |
| Feb. 19, 2025 | ADMA BIOLOGICS, INC. | $ADMA | Tade Brad L. | CFO and Treasurer | A | Stock Option (right to buy) | 93023 | $0.00 | 93,023.0000 | 243,342,466 | 9999.99% | 0.04% |
| Nov. 22, 2024 | ADMA BIOLOGICS, INC. | $ADMA | Tade Brad L. | CFO and Treasurer | S | Common Stock | 15000 | $21.15 | 199,433.0000 | 223,977,315 | 7.00% | 0.01% |
| July 24, 2024 | ADMA BIOLOGICS, INC. | $ADMA | Tade Brad L. | CFO and Treasurer | A | Stock Option (right to buy) | 115100 | $0.00 | 115,100.0000 | 223,977,315 | 9999.99% | 0.05% |
| July 24, 2024 | ADMA BIOLOGICS, INC. | $ADMA | Tade Brad L. | CFO and Treasurer | A | Common Stock | 72400 | $0.00 | 214,433.0000 | 223,977,315 | 50.97% | 0.03% |